Sofía D. Merajver
Impact in
- Cancer Research top 0.2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
Papers in
-
- Protein Kinase Regulation and GTPase Signaling 12
- Epigenetics and DNA Methylation 8
- Oncology 70
- Cancer Cells and Metastasis 21
- Global Cancer Incidence and Screening 20
- Co-authors
- Celina G. Kleer (36 shared papers)George J. Brewer (14 shared papers)Zhi-Fen Wu (10 shared papers)Quintin Pan (9 shared papers)Alejandra C. Ventura (16 shared papers)Quintin Pan (11 shared papers)Li Bao (6 shared papers)Theodoros N. Teknos (12 shared papers)
- Journals
- Cancer Research (22 papers)Breast Cancer Research and Treatment (18 papers)Journal of Clinical Oncology (10 papers)PLoS ONE (7 papers)Neoplasia (6 papers)
- Partner nations
- United StatesEgyptGhana
In The Last Decade
Sofía D. Merajver
252 papers receiving 12.0k citations
Peers
Comparison fields: 5 of 192
- Cancer Research 2.8k
- Oncology 3.8k
- Molecular Biology 4.9k
- Genetics 1.9k
- Immunology and Allergy 344
Countries citing papers authored by Sofía D. Merajver
This map shows the geographic impact of Sofía D. Merajver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofía D. Merajver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofía D. Merajver more than expected).
Fields of papers citing papers by Sofía D. Merajver
This network shows the impact of papers produced by Sofía D. Merajver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofía D. Merajver. The network helps show where Sofía D. Merajver may publish in the future.
Co-authors
The 25 scholars most cited alongside Sofía D. Merajver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 260 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis. | 2002 | 367 |
| 2 | 2008 | 338 | |
| 3 | 2010 | 334 | |
| 4 | 1995 | 307 | |
| 5 | 2018 | 280 | |
| 6 | Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. | 2000 | 272 |
| 7 | 1996 | 269 | |
| 8 | RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype. | 2000 | 257 |
| 9 | 2006 | 218 | |
| 10 | 2006 | 208 | |
| 11 | 2012 | 206 | |
| 12 | A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype. | 1999 | 206 |
| 13 | 2013 | 194 | |
| 14 | 2001 | 186 | |
| 15 | 2007 | 175 | |
| 16 | 2002 | 167 | |
| 17 | 2016 | 166 | |
| 18 | 2001 | 162 | |
| 19 | Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma. | 1996 | 157 |
| 20 | Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer. | 2003 | 154 |
About Sofía D. Merajver
Sofía D. Merajver is a scholar working on Molecular Biology, Oncology, Genetics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 260 papers that have together received 12.3k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (45 papers), Cancer Genomics and Diagnostics (22 papers), Cancer Cells and Metastasis (21 papers), Global Cancer Incidence and Screening (20 papers), Breast Cancer Treatment Studies (17 papers), Cell Adhesion Molecules Research (14 papers), Protein Kinase Regulation and GTPase Signaling (12 papers) and Epigenetics and DNA Methylation (8 papers). The work is most often cited by research in Cancer Research (2.8k citations), Oncology (3.8k citations), Molecular Biology (4.9k citations), Genetics (1.9k citations) and Immunology and Allergy (344 citations). Sofía D. Merajver has collaborated with scholars based in United States, Egypt and Ghana. Frequent co-authors include Celina G. Kleer, George J. Brewer, Zhi-Fen Wu, Quintin Pan, Alejandra C. Ventura, Quintin Pan, Li Bao, Theodoros N. Teknos, Yanhong Zhang and Mousumi Banerjee. Their work appears in journals such as Cancer Research, Breast Cancer Research and Treatment, Journal of Clinical Oncology, PLoS ONE and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.